CJMBHIGH SIGNALFINANCIAL10-K

CJMB shows deteriorating operational performance with declining revenue and profitability while substantially increasing operating expenses and total liabilities.

The company faces significant operational challenges with revenue declining 12.8% while SG&A expenses grew substantially, creating negative operating leverage that compressed profitability. The material increase in total liabilities combined with reduced stockholders' equity suggests potential financial stress, particularly concerning for a smaller company with heavy customer concentration.

Comparing 2026-03-31 vs 2025-03-28View on EDGAR →
FINANCIAL ANALYSIS

CJMB's financial position weakened materially as revenue declined to $5.7M while operating expenses expanded substantially, leading to compressed gross profit margins. The balance sheet deteriorated with total liabilities increasing 80.6% to $3.4M and stockholders' equity declining 26.6% to $2.3M, indicating potential liquidity pressures. The combination of declining operational performance and increasing financial obligations signals meaningful financial stress for this smaller company.

FINANCIAL STATEMENT CHANGES
Total Liabilities
Balance Sheet
+80.6%
$1.9M→$3.4M

Liabilities grew 80.6% — significant increase in debt or obligations, assess impact on financial flexibility.

SG&A Expense
P&L
+77.7%
$4.8M→$8.6M

SG&A up 77.7% — significant increase in sales or administrative costs, monitor impact on operating leverage.

Dividends Paid
Cash Flow
-55%
$7.4M→$3.3M

Dividends cut 55% — significant signal of cash flow stress or capital reallocation priorities.

Inventory
Balance Sheet
+53.6%
$158K→$243K

Inventory surged 53.6% — growing significantly faster than typical sales pace; potential demand softening or supply chain overcorrection.

Accounts Receivable
Balance Sheet
-44.9%
$623K→$343K

Receivables declined — improved collection efficiency or conservative revenue recognition.

Stockholders Equity
Balance Sheet
-26.6%
$3.2M→$2.3M

Equity decreased 26.6% — buybacks or losses reducing book value, monitor solvency ratios.

Gross Profit
P&L
-17.9%
$2.6M→$2.1M

Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.

Total Assets
Balance Sheet
+13.6%
$5.1M→$5.8M

Asset base grew 13.6% — expansion through organic growth, acquisitions, or capital deployment.

Revenue
P&L
-12.8%
$6.6M→$5.7M

Revenue softened 12.8% — monitor whether this is cyclical or structural.

Current Liabilities
Balance Sheet
+10.3%
$1.3M→$1.4M

Current liabilities rose 10.3% — increased short-term obligations, watch current ratio.

LANGUAGE CHANGES
NEW — 2026-03-31
PRIOR — 2025-03-28
ADDED
For purposes of the foregoing calculation only, all directors and the executive officers who were SEC reporting persons of the Registrant as of June 30, 2025 have been deemed affiliates.
As of March 25, 2026, the Company had 5,627,368 shares of common stock, $ 0.001 par value, issued and outstanding.
Changes in and Disagreements with Accountants and Financial Disclosure 32 Item 9A.
We are headquartered at 244 Flightline Drive, Spring Branch, TX 78070.
We also established an entity, Callan JMB Services (India) Private Limited is domiciled in Pune, Maharashtra, India and is 99.9% owned by Callan JMB and has no operations or activities as of December 31, 2025.
+7 more — sign up free →
REMOVED
The registrant s common shares began trading on the NASDAQ Capital Market American on February 5, 2025.
As of March 28, 2025, the Company had 4,443,569 shares of common stock, $ 0.001 par value, issued and outstanding.
Changes in and Disagreements with Accountants and Financial Disclosure 33 Item 9A.
We are headquartered at 244 Flightline Dr., Spring Branch, TX 78070.
Our Customers As of December 31, 2024, our top three customers, the Customer 1 (50.6%), Customer 2 (17.5%), and Customer 3 (13.3%), collectively accounted for approximately 81.4% of our revenue.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →